안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report.
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B. (2024) Mol Pharm. Dec 16
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pbbm, mechanistic absorption, drug product specification, safe space, vbe, bioequivalence
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules.
Bi F, Yuan T, Zhang B, Li J, Lin Y, Yang J. (2024) AAPS PharmSciTech. Dec 17;26(1):13
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pbbm, vbe, bioequivalence, dissolution method, dissolution specification, modified release, safe space
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.
Khan MS, Murthy A, Ahmed T. (2024) AAPS PharmSciTech. 2024 Dec 17;26(1):14
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, eye distribution, ivive, ocat, ocular drug delivery
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox Approach.
Cable S, Baltazar MT, Bunglawala F, Carmichael PL, Contreas L, Dent MP, Houghton J, Kukic P, Malcomber S, Nicol B, Przybylak KR, Punt A, Reynolds G, Reynolds J, Scott S, Tang D, Middleton AM. (2024) Toxicol Sci. Dec 18
Keywords: gastroplus, pbpk modeling, pbk modeling, physiologically based kinetics, next generation risk assessment, ngra, new approach methodologies, nam
주소 : 서울특별시 강남구 역삼로112 하나빌딩 301호
안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report.
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B. (2024) Mol Pharm. Dec 16
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pbbm, mechanistic absorption, drug product specification, safe space, vbe, bioequivalence
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules.
Bi F, Yuan T, Zhang B, Li J, Lin Y, Yang J. (2024) AAPS PharmSciTech. Dec 17;26(1):13
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pbbm, vbe, bioequivalence, dissolution method, dissolution specification, modified release, safe space
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.
Khan MS, Murthy A, Ahmed T. (2024) AAPS PharmSciTech. 2024 Dec 17;26(1):14
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, eye distribution, ivive, ocat, ocular drug delivery
Advancing Systemic Toxicity Risk Assessment: Evaluation of a NAM-based Toolbox Approach.
Cable S, Baltazar MT, Bunglawala F, Carmichael PL, Contreas L, Dent MP, Houghton J, Kukic P, Malcomber S, Nicol B, Przybylak KR, Punt A, Reynolds G, Reynolds J, Scott S, Tang D, Middleton AM. (2024) Toxicol Sci. Dec 18
Keywords: gastroplus, pbpk modeling, pbk modeling, physiologically based kinetics, next generation risk assessment, ngra, new approach methodologies, nam